Teen's broken heart mends--literally--after grafted heart is removed

Join Our Community of Science Lovers!

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American



On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Fourteen years after a risky operation to save the life of an infant suffering heart failure, a team of U.K. doctors is claiming success. Hannah Clark (now aged 16)—who as a baby had a donor heart grafted onto her own—has made a full recovery, three years after the transplanted organ was removed, the doctors claim in an article published online today by The Lancet.

The "full recovery" part comes from the fact that Clark no longer needs to take immunosuppression medication that caused her to suffer from a type of cancer called Epstein-Barr-virus-associated post-transplant lymphoproliferative disorder (EBV PTLD), report the authors, who include Victor Tsang, a pediatric cardiac surgery specialist, and Magdi Yacoub, a professor of cardiothoracic surgery at Imperial College London (both led the surgery in February 2006).

Clark's doctors walked a tightrope for several years: the immunosuppressant drugs needed to keep her body from rejecting the donor heart were also responsible for her PTLD. In the end, they decided to remove the donor heart so that immunosuppression could be stopped altogether.

Their success "shows that the heart can indeed repair itself if given the opportunity," Douglas Zipes, a past president of the American College of Cardiology, told the Huffington Post. Miguel Uva, chairman of the European Society of Cardiology's group on cardiovascular surgery, called Clark's case "a miracle," adding that it was rare for patients' hearts to simply get better on their own.

Hannah's father, Paul Clark, described to CNN the difficult decision the family had to make at the time: "If she'd never had it done, she wouldn't be here. "In the very beginning it was a 50/50 chance she wasn't going to make the operation. But in the next one it was even greater because it had never been done before. But we had to take that risk."

The Los Angeles Times has a diagram of how the two hearts functioned together.

Image ©iStockphoto.com/ Tamara Murray

Larry Greenemeier is the associate editor of technology for Scientific American, covering a variety of tech-related topics, including biotech, computers, military tech, nanotech and robots.

More by Larry Greenemeier

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe